Phibro Animal Health | PAHC - Current Assets


Phibro Animal Health reported $894.07M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Align Technology USD 2.66B 7.62M Jun/2026
ANI Pharmaceuticals USD 825.43M 78.35M Jun/2026
Aurora Cannabis CAD 397.45M 48.38M Mar/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Canopy Growth CAD 529.47M 4.8M Mar/2026
Corcept Therapeutics USD 439.68M 13.64M Jun/2026
Eli Lilly USD 64.67B 9.84B Jun/2026
Henry Schein USD 4.6B 104M Jun/2026
Idexx Laboratories USD 1.51B 55.41M Jun/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Merck USD 36.68B 1.66B Jun/2026
Nektar Therapeutics USD 589.04M 322.77M Mar/2026
Pacira USD 615.21M 100.25M Jun/2026
Phibro Animal Health USD 894.07M 31.88M Mar/2026
Prestige Brands USD 496.81M 65.33M Jun/2026
Supernus Pharmaceuticals USD 723.5M 8.08M Jun/2026
Zoetis USD 6.36B 118M Jun/2026